Appointment of Non-Executive Director

RNS Number : 0888D
Alliance Pharma PLC
26 January 2015
 

For immediate release

26 January 2015

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Appointment of Non-Executive Director

 

Alliance Pharma plc ("Alliance" or the "Company") is pleased to announce the appointment of Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.

 

Nigel is Chief Executive of Procserve Holdings Limited, a leading company in enabling secure transactions online. He is also currently a non-executive director of Anite plc.   He has previously held senior positions at Micro Focus International plc, Nokia, Symbian Software Ltd, Tertio Telecoms Limited, Cable and Wireless plc, Glasgow Royal Infirmary NHS Trust and BT plc.

 

Commenting on the appointment, Andrew Smith, Chairman of Alliance, said:

 

"We are delighted to welcome Nigel to the Board of Alliance. His breadth of business experience and his significant exposure to international and European markets make him a strong addition to the Alliance team."

 

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Nigel Richard Clifford, aged 55 years, has been a director of the following companies during the five years preceding the date of this announcement:

 

Current directorships

Past Directorships

Anite plc

Symbian Limited

Procserve Holdings Limited

Symbian Software Limited

Procserve Services Limited

Micro Focus International plc

Procserve Shared Services Limited

 

Procserve Solutions Limited

 

Procserve Supplier Solutions Limited

 

                                               

                                                           

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive

 

Richard Wright, Finance Director

 

www.alliancepharma.co.uk

 

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Sophie Cowles

 

 

 

Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Freddie Barnfield

 

Corporate Broking: David Poutney

 

 

 

Notes to editors:

 

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADBGDBISDBGUU
UK 100